Wire · opportunities
J&J gets FDA authorization for Ottava robot, teeing up competition with Intuitive
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 22 July 2026 · Fusion42 review
Johnson & Johnson received FDA authorization for its Ottava robotic surgery system, directly challenging Intuitive Surgical's market dominance in surgical robotics. Analysts express scepticism about J&J's ability to capture meaningful market share from the entrenched leader.
This Wire brief sits within Fusion42's coverage of Digital Health.
◆ ◆ The Wire takeaway
If you build surgical instruments, training software, or hospital integration tools for robotic surgery, you now have a second buyer in the market. Intuitive's installed base just became defensible territory worth fighting for—call those hospital procurement teams this week.
◆ Coverage
1 source · 22 Jul 2026
◆ Related on Wire
◆ Topics